True North

Premium

People

22 November, 2024

Kedaara Capital ropes in former executive from True North

Private equity firm Kedaara Capital, which had raised India’s largest sector-agnostic PE fund earlier this year and has made a ......

Premium

Healthcare

20 November, 2024

Bottomline: PE-backed Integrace's margins shrink, revenue growth marginally better

Drugmaker Integrace Pvt Ltd, which has Indian private equity firm True North and Singapore state investment firm Temasek on its cap ......

Premium

Finance

21 October, 2024

Creador, True North's exit plans move ahead as portfolio companies get IPO nod

Private equity firms True North and Creador’s separate plans to monetize their investments are moving forward with two of their ......

Premium

Finance

04 October, 2024

ChrysCap hits the road to raise biggest PE fund ever in India

Homegrown private equity firm ChrysCapital has launched its tenth fund, which may turn out to be the largest PE fund ever ......

Premium

General

03 October, 2024

Grapevine: True North plans an exit; Edelweiss Alts, CarDekho, Afcons in IPO news

Private equity firm True North is considering a complete exit from Shree Digvijay Cement Company, where it holds a 54.83% ......

Premium

Finance

13 September, 2024

True North hires former Investec exec for private credit vertical

Mumbai-based True North, a homegrown private equity firm which wrapped up fundraising for its maiden private credit fund earlier this ......

Premium

Healthcare

10 September, 2024

Exclusive: Biocon weighs fresh funding for PE-backed biosimilars unit

Biocon Ltd is looking to raise fresh funding for its biosimilars unit that has previously secured capital from five private ......

Premium

Healthcare

07 August, 2024

True North-backed Integrace set to add new names on cap table

Mumbai-based pharmaceutical player Integrace Pvt. Ltd, backed by Singapore’s Temasek and homegrown private equity firm True North, is in discussions to ......

Premium

General

10 July, 2024

Grapevine: True North-backed Anthem Bio mulls IPO; CVC Capital India head resigns

Anthem Biosciences Pvt Ltd, a Bengaluru-based contract drug researcher and manufacturer, is contemplating an initial public offering (IPO) in India that ......

Premium

Healthcare

21 May, 2024

Bottomline: True North-backed Anthem Bio's margins shrink again, revenue remains in a spot

Anthem Biosciences Pvt Ltd had nearly doubled its revenue in FY21, the same year in which it hit a billion-dollar valuation following ......